The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study
Authors:
- 12 November 1999
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 39 (11-12) , 1266-1270
Abstract
BACKGROUND: There is a need for more comprehensive work dealing with the quality of plasma collected by automated plasmapheresis using different final concentrations of citrate anticoagulant. A prospective study was performed to examine the influence of three concentrations of sodium citrate on the levels of clotting factors and markers of activated hemostasis and fibrinolysis.STUDY DESIGN AND METHODS: Fifty‐one experienced plasma donors were recruited for subsequent 750‐mL plasmapheresis procedures using 4‐percent (wt/vol) sodium citrate. Anticoagulant‐to‐blood ratios of 1:16.6, 1:14.2, and 1:12.5 were used, corresponding to sodium citrate concentrations of 6 percent, 7 percent, and 8 percent (vol/vol), respectively. Between two plasmapheresis procedures, there was a washout period of 7 days. Determinations were made of the plasma levels of fibrinogen and factors V, VII, VIII, and IX, as well as antithrombin, tissue‐type plasminogen activator, and several markers of activated hemostasis and fibrinolysis: activated factor VII, prothrombin splits products, d‐dimers, and β‐thromboglobulin.RESULTS: The plasma samples anticoagulated with 6‐percent citrate contained significantly higher levels of factors V, VIII, and IX than the samples anticoagulated with 8‐percent citrate (pCONCLUSION: A reduction in the final citrate concentration of plasma collected by automated plasmapheresis results in higher yields of factors V, VIII, and IX without activation of hemostasis. More comprehensive studies should confirm previous work dealing with the establishment of the lowest citrate concentration acceptable in plasma used as therapeutic fresh‐frozen plasma or as starting material for the manufacture of plasma derivatives.Keywords
This publication has 18 references indexed in Scilit:
- Improved Blood Preservation with 0.5CPD Erythro‐Sol. Coagulation Factor VIII Activity and Erythrocyte Quality after Delayed Separation of BloodVox Sanguinis, 1998
- The potential impact of recombinant factor VIII on hemophilia care and the demand for blood and blood productsTransfusion Medicine Reviews, 1997
- Activated Factor VIII inTherapeutic Preparations:Analysis by UltracentrifugationVox Sanguinis, 1996
- Practice Guidelines for Blood Component TherapyAnesthesiology, 1996
- Collection and transfusion of blood and blood components in the United States, 1989Transfusion, 1993
- Effect of citrate anticoagulants on factor VIII levels in plasmaTransfusion, 1988
- Studies on the Procurement of Blood Coagulation Factor VIII in vitro Studies on Blood Components Prepared in Half‐Strength Citrate AnticoagulantVox Sanguinis, 1987
- Freezing of plasma and recovery of factor VIIITransfusion, 1986
- Stability of VIII:C in plasma: The dependence on protease activity and calciumThrombosis Research, 1983
- Purification and Stabilization of Factor VNature, 1963